|
Orthologous residues
|
|
NMDAR1 (human): S890‑p, NMDAR1 iso2 (human): ‑, NMDAR1 iso5 (human): S911‑p, NMDAR1 (mouse): S890‑p, NMDAR1 iso2 (mouse): ‑, NMDAR1 iso3 (mouse): S911‑p, NMDAR1 (rat): S890‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
'brain, hippocampus', 293 (epithelial), QT-6 (fibroblast)
|
|
Cellular systems studied:
cell lines, tissue
|
|
Species studied:
human, quail, rat
|
|
Comments:
transfected 293 and QT-6 cells, and hippocampal slices
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
phorbol ester
|
|
|
|
increase
|
|
|
forskolin
|
|
|
|
no change compared to control
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|